Austin, TX, United States of America

Mystic Pharmaceuticals, Inc.


USPTO Granted Patents = 16

% Expired Patents = 50.0



Forward Citations = 161

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Timothy R Sullivan (11 out of 12 patents)

silverMedal Jeffrey Nelson (9 out of 12 patents)

bronzeMedal Jesse Hancock (3 out of 3 patents)

4.  Michael W Shaw (2 out of 4 patents)

5.  James Durham (2 out of 2 patents)

6.  Christopher D Shay (2 out of 2 patents)

7.  Allen E Brandenburg (1 out of 14 patents)

8.  Jeffrey Gjertsen (1 out of 2 patents)

9.  Phillip Goodman (1 out of 1 patent)

10.  Jeff Gjertsen (1 out of 3 patents)

11.  Jon Olson (1 out of 7 patents)

12.  Timothy Sullivan (2 patents)

13.  Jesse Ryan Hancock (0 patent)

14.  Jesse Ryan Hancock (0 patent)


16 patents:

Company Overview
Mystic Pharmaceuticals, Inc. is a biotechnology company based in Austin, Texas, focused on developing innovative drug delivery systems. The organization specializes in creating advanced formulations and devices that enhance the efficacy and safety of pharmaceutical products. Mystic Pharmaceuticals aims to address unmet medical needs through its proprietary technologies, which are designed to improve patient outcomes and streamline the administration of medications. The company is committed to advancing healthcare solutions that are both effective and accessible.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#197 in Austin, TX

#1,216 in Texas

#19,922 in US

#37,831 in the World

Austin, TX (US)
Austin, TX, United States of America
Forward Citations = 161

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mystic Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/mystic-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…